Biotech

All Articles

Praxis epilepsy drug lowers confiscations in phase 2 trial

.Praxis Accuracy Medicines has scored yet another midphase win in epilepsy this year, along with its...

Three officers resign as Dyne articles combined information for DMD prospect

.After running away a medical hold several years back, Dyne Therapeutics has uncovered brand-new sta...

Arrowhead fires off stage 3 information in uncommon metabolic disease ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its hand in front of a potential showdown with Ionis, posting p...

Pfizer, Valneva present lyme ailment chance efficient for second booster

.Pfizer as well as Valneva may have concerning pair of additional years to wait just before they mak...

Fierce Biotech Managing Editor Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Allow's dive into a chat with Ayla Ellison, Tough Biotech Managing Editor as well as Michelle Benz ...

New data demonstrate how Bayer's asundexian failed to avoid strokes

.Bayer suspended the period 3 test for its own aspect XIa inhibitor asundexian behind time last year...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its own multiple sclerosis (MS) med tolebrutinib to the F...

Galapagos' stockpile as fund reveals intent to form its own advancement

.Galapagos is actually happening under additional tension coming from capitalists. Having actually c...

Cell- centered Sana gathers very first CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, firings ...

Allist pays off Jacobio $21M, landing job in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has bought itself a starring job in China's KRAS market, paying Jac...